Husch Blackwell Earns Appellate Win for Ventria Bioscience at the Federal Circuit
February 11, 2025
February 11, 2025
KANSAS CITY, Missouri, Feb. 11 -- Husch Blackwell, a law firm, issued the following news release:
Husch Blackwell prevailed at the U.S. Court of Appeals for the Federal Circuit on behalf of Kansas-based client Ventria Bioscience (d/b/a InVitria and ExpressTec), when a three-judge panel affirmed a U.S. International Trade Commission's 2022 decision that found Wuhan Healthgen Biotechnology Corp. and its distributors in violation of U.S. trade law. The Federal Circuit affirmed bot . . .
Husch Blackwell prevailed at the U.S. Court of Appeals for the Federal Circuit on behalf of Kansas-based client Ventria Bioscience (d/b/a InVitria and ExpressTec), when a three-judge panel affirmed a U.S. International Trade Commission's 2022 decision that found Wuhan Healthgen Biotechnology Corp. and its distributors in violation of U.S. trade law. The Federal Circuit affirmed bot . . .